Group 1 - Health 160 International Limited successfully listed on the Hong Kong Stock Exchange on September 17, 2025, with a share price of HKD 11.89, raising a total of HKD 400 million [2] - The company focuses on integrated digital healthcare services, aiming to become a leading online and offline healthcare service provider in China [4] - The IPO received an overwhelming response, with a subscription rate of 751.8 times for the public offering, marking it as the first digital healthcare stock under the new pricing and allocation rules in Hong Kong [4] Group 2 - Shenwan Hongyuan Hong Kong acted as the joint sponsor, overall coordinator, joint global coordinator, joint bookrunner, and joint lead manager for the IPO, showcasing its capabilities in the Hong Kong IPO and healthcare sectors [4] - The successful listing reflects Shenwan Hongyuan's strength in resource integration and its client-centric service philosophy, emphasizing the synergy of "investment + investment banking + research" [4]

来源：市场资讯 （来源：申万宏源融成） 2025年9月17日，健康160国际有限公司（以下简称"健康160"或"公司"）成功于香港联交所主板上市， 股份代号为2656.HK，最终定价为每股11.89港元，融资规模为4亿港币。 申万宏源香港担任本次发行的联席保荐人、整体协调人、联席全球协调人、联席账簿管理人及联席牵头 经办人。 公司亮点 本项目的圆满发行，不仅充分体现了申万宏源在港股IPO及医疗健康领域的实力与资源整合能力，也再 次印证了我们以客户为中心的服务理念及依托申万宏源"投资+投行+研究"三位一体协同优势。 未来，申万宏源香港将继续发挥境内外联动优势，推进国际化及境内外一体化战略，借助境内外市场互 联互通带来的机遇，打造"双循环"的大投行生态圈，全力服务新质生产力发展，服务国家高水平对外开 放战略。 项目亮点 公司专注数字医疗健康综合服务，致力于构筑中国领先的线上线下一体化医疗健康服务入口，成 为每个人最贴心的健康守护者。 自成立以来，公司已累计连接超过44,600家医疗健康机构，其中包括超过14,400家医院 (包括3,430 家三级医院) 及超过30,200家基层医疗卫生机构。 自成立以来，公司已累 ...